cabotegravir 30 MG Oral Tablet [Vocabria]
- RxCUI
- 2475205
- RxNorm name
- cabotegravir 30 MG Oral Tablet [Vocabria]
- Display name
- cabotegravir 30 MG Oral Tablet [Vocabria]
- Full name
- cabotegravir 30 MG Oral Tablet [Vocabria]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vocabria | CABOTEGRAVIR SODIUM | ViiV Healthcare Company | 66d450fb-cca4-476c-b0c7-c0730e3e4cf3 | 2025-04-11 | Warnings, Adverse reactions | 2475205 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 66d450fb-cca4-476c-b0c7-c0730e3e4cf3 | VOCABRIA 30 MG Oral Tablet [PSN] · cabotegravir 30 MG Oral Tablet [Vocabria] [SBD] · Vocabria 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet [SY] · Vocabria 30 MG Oral Tablet [SY] | 4 | 8 | These highlights do not include all the information needed to use VOCABRIA safely and effectively. See full prescribing information for VOCABRIA. VOCABRIA (cabotegravir) tablets, for oral use Initial U.S. Approval: 2021 | 20250411 |